ICD-10 Coding for Chemotherapy-Induced Neuropathy(G62.0, T45.1x5*)
Complete ICD-10-CM coding and documentation guide for Chemotherapy-Induced Neuropathy. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Chemotherapy-Induced Neuropathy
G60-G64Primary Range
Polyneuropathies and other disorders of the peripheral nervous system
This range includes codes for neuropathies, specifically drug-induced neuropathy under G62.0.
Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
This range includes codes for adverse effects of drugs, specifically T45.1x5* for antineoplastic drugs.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| G62.0 | Drug-induced polyneuropathy | Use when neuropathy is directly linked to chemotherapy agents. |
|
| T45.1x5* | Adverse effect of antineoplastic and immunosuppressive drugs | Use when documenting adverse effects of chemotherapy drugs. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for chemotherapy-induced neuropathy
Essential facts and insights about Chemotherapy-Induced Neuropathy
Primary ICD-10-CM Codes for chemotherapy induced neuropathy
Decision Criteria
clinical Criteria
- Presence of neuropathy symptoms post-chemotherapy
documentation Criteria
- Explicit causal language linking chemotherapy to neuropathy
Applicable To
- Chemotherapy-induced neuropathy
Excludes
- G62.9 (Unspecified polyneuropathy)
Clinical Validation Requirements
- Explicit documentation linking neuropathy to chemotherapy
- Symptoms such as numbness, tingling, and pain in a glove-stocking distribution
- Nerve conduction studies or skin biopsies supporting diagnosis
Code-Specific Risks
- Failure to document the causal relationship with chemotherapy
Coding Notes
- Ensure documentation explicitly states the link between chemotherapy and neuropathy.
T45.1x5* - Adverse effect of antineoplastic and immunosuppressive drugs
Use when documenting adverse effects of chemotherapy drugs.
Applicable To
- Adverse effects of chemotherapy drugs
Clinical Validation Requirements
- Documentation of drug name and temporal relationship to chemotherapy
Coding Notes
Ensure proper sequencing based on the encounter purpose.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Adverse effect of antineoplastic and immunosuppressive drugs
T45.1x5*Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Chemotherapy-Induced Neuropathy to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code G62.0.
Impact
Clinical: May lead to misdiagnosis or inappropriate treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims or reduced reimbursement.
Mitigation Strategy
Ensure all documentation includes causal language., Train staff on proper documentation techniques.
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with ICD-10 specificity requirements., Data Quality: Decreases accuracy of clinical data.
Mitigation Strategy
Ensure documentation specifies chemotherapy as the cause of neuropathy.
Impact
Failure to document the link between chemotherapy and neuropathy.
Mitigation Strategy
Implement regular training and audits to ensure compliance.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Chemotherapy-Induced Neuropathy, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Chemotherapy-Induced Neuropathy
Use these documentation templates to ensure complete and accurate documentation for Chemotherapy-Induced Neuropathy. These templates include all required elements for proper coding and billing.
Oncology Progress Note
Specialty: OncologyRequired Elements
- Causal language linking chemotherapy to neuropathy
- Temporal relationship of symptoms
- Functional impact on patient
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Chemotherapy-Induced Neuropathy? Ask your questions below.